Copyright
©The Author(s) 2020.
World J Clin Cases. Jul 26, 2020; 8(14): 2930-2941
Published online Jul 26, 2020. doi: 10.12998/wjcc.v8.i14.2930
Published online Jul 26, 2020. doi: 10.12998/wjcc.v8.i14.2930
Figure 1 Flow chart of case selection.
BCS: Budd-Chiari syndrome; TIPS: Transjugular intrahepatic portosystemic shunt.
Figure 2 Frequency of restenosis occurrence after recanalization and corresponding treatment selection.
BCS: Budd-Chiari syndrome; PTA: Percutaneous transluminal angioplasty.
Figure 3 Survival rates of Budd-Chiari syndrome patients with restenosis.
A: The cumulative survival rate for a total of 60 patients with restenosis; B: The cumulative survival rate for the patients in the percutaneous transluminal angioplasty group; C: The cumulative survival rate for the patients in the percutaneous transluminal angioplasty + stent group; and D: Comparison of the cumulative survival rates for the treated and untreated patients. PTA: Percutaneous transluminal angioplasty.
- Citation: Zhang W, Tian YL, Wang QZ, Chen XW, Li QY, Han JH, Chen XD, Xu K. Restenosis after recanalization for Budd-Chiari syndrome: Management and long-term results of 60 patients. World J Clin Cases 2020; 8(14): 2930-2941
- URL: https://www.wjgnet.com/2307-8960/full/v8/i14/2930.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i14.2930